• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:陶禹,刘文娟,马茜茜,付丹妮.基于网络药理学分析苍术-桂枝治疗非酒精性脂肪性肝炎的作用机制[J].药学研究,2023,42(10):759-764[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2425次   下载 3271次 本文二维码信息
码上扫一扫!
基于网络药理学分析苍术-桂枝治疗非酒精性脂肪性肝炎的作用机制
陶禹1,2,刘文娟1,2,马茜茜1,2,付丹妮1,2
字体:加大+|默认|缩小-
(1.内蒙古民族大学医学院,内蒙古 通辽 028000;2.内蒙古自治区蒙药心脑血管药理学重点实验室,内蒙古 通辽 028000)
摘要:
目的 网络药理学筛选苍术-桂枝治疗非酒精性脂肪性肝炎的有效成分和靶点。方法 应用TCMSP和Swiss查找苍术、桂枝的活性成分的靶点,通过OMIM和GeneCards数据检索非酒精性脂肪性肝炎的靶点,获取交集靶点,利用Cytoscape3.6.0构建苍术-桂枝与非酒精性脂肪性肝炎的“药物-成分-疾病-靶点”的网络图,筛选出关键靶点,进行GO和KEGG富集分析,最后利用分子对接验证关键靶点。结果 得到苍术-桂枝有效活性成分16个,交集靶点77个,蛋白互作分析(PPI)得到ACE、APOB、CAT、TP53、EGFR、PPARG等16个核心靶点。KEGG和GO结果显示:主要影响脂质颗粒、细胞外间隙、内质网等10种细胞成分,脂肪酸结合、肝素结合、脂质转运体活性等10种分子功能,作用于炎症反应、胆固醇稳态、胆固醇代谢过程等10种生物过程,主要通过脂质与动脉粥样硬化、胰岛素抵抗、非酒精性脂肪肝等13种通路对非酒精性脂肪性肝炎起作用,分子对接结果证明,16中有效成分与靶点具有较强的结合能。结论 苍术-桂枝改善非酒精性脂肪性肝炎的作用机制可能通过胰岛素抵抗、非酒精性脂肪肝等通路实现的,具有多个靶点,多个成分,多条通路的特点。
关键词:  网络药理学  苍术  桂枝  非酒精性脂肪性肝炎  作用机制
DOI:10.13506/j.cnki.jpr.2023.10.003
基金项目:内蒙古自治区本级事业单位引进人才科研启动绩效项目(No.RCQD20001)
Analysis of the mechanism of herb pair containing Atractylodis Rhizoma and Cinnamomi Ramulus against nonalcoholic Steatohepatitis on network pharmacology
TAO Yu1,2,LIU Wenjuan1,2,MA Qianqian1,2,FU Danni1,2
(1.Medical college, Inner Mongolia Minzu University, Tongliao 028000, China; 2.Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao 028000, China)
Abstract:
Objective The effective components and action targets of Atractylodis Rhizoma and Cinnamomi Ramulus can be screened using network pharmacology. Methods TCMSP and Swiss databases were used to search for active targets of A. Rhizoma and C. Ramulus, and OMIM and GeneCards database used to search for targets of nonalcoholic steatohepatitis. A "drug-composition-disease targeting" network was constructed using Cytoscape software and protein-protein interaction network, to screen out key targets. Then, validate the results by molecular docking. Results There are 16 active ingredients and 383 targets for Atractylodis Rhizoma and Cinnamomi Ramulus, 656 nonalcoholic steatohepatitis targets and 77 intersecting targets of A. Rhizoma-C. Ramulus and nonalcoholic steatohepatitis. Protein-protein 16 core targets of ACE,APOB,CAT,TP53,EGFR,PPARG were generated by PPI. Enrichment analysis revealed 10 cellular components, including lipid particle, macromolecular complex complexes and endoplasmic reticulum. 10 biological processes such as fatty acid binding, lipid transporter activity, cholesterol homeostasis, cellular response to cholesterol metabolism, insulin secretion regulation, active regulation of inflammatory response. lipid and atherosclerosis, insulin resistance, non-alcoholic fatty liver disease, hepatocellular carcinoma etc. 13 signal paths for Nonalcoholic steatohepatitis's treatment. Molecular docking proved that A. Rhizoma-C. Ramulus has a strong binding ability to treat components and targets of Nonalcoholic steatohepatitis. Conclusion The mechanism of action of A. Rhizoma-C. Ramulus against Nonalcoholic steatohepatitis may be realized through insulin resistance, steatosis, etc. Characterized by multi-targeting, multi-component, multi-channel synergism, and co-resistance to NASH.
Key words:  Network pharmacology  Atractylodis Rhizama  Cinnamomi Ramulus  Nonalcoholic steatohepatitis  Mechanism of action
今日访问量:2490    总访问量:55338932
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司